BCAM
GSK icon

Boston Common Asset Management’s GSK GSK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-24,158
Closed -$895K 306
2023
Q4
$895K Sell
24,158
-10
-0% -$370 0.02% 267
2023
Q3
$876K Sell
24,168
-5,670
-19% -$206K 0.02% 259
2023
Q2
$1.06M Hold
29,838
0.02% 257
2023
Q1
$1.06M Buy
29,838
+65
+0.2% +$2.31K 0.02% 255
2022
Q4
$1.05M Hold
29,773
0.05% 161
2022
Q3
$876K Sell
29,773
-881
-3% -$25.9K 0.05% 170
2022
Q2
$1.33M Buy
30,654
+5,290
+21% +$230K 0.07% 161
2022
Q1
$1.11M Buy
25,364
+5
+0% +$218 0.05% 169
2021
Q4
$1.12M Sell
25,359
-30
-0.1% -$1.32K 0.05% 167
2021
Q3
$970K Sell
25,389
-744,030
-97% -$28.4M 0.04% 169
2021
Q2
$30.6M Buy
769,419
+12,941
+2% +$515K 1.32% 24
2021
Q1
$27M Buy
756,478
+89,194
+13% +$3.18M 1.7% 8
2020
Q4
$24.6M Buy
667,284
+13,032
+2% +$480K 1.71% 10
2020
Q3
$24.6M Buy
654,252
+27,008
+4% +$1.02M 2.34% 6
2020
Q2
$25.6M Buy
627,244
+44,097
+8% +$1.8M 2.73% 5
2020
Q1
$22.1M Buy
+583,147
New +$22.1M 3.12% 4
2017
Q4
Sell
-10,445
Closed -$424K 187
2017
Q3
$424K Hold
10,445
0.05% 167
2017
Q2
$450K Hold
10,445
0.06% 163
2017
Q1
$440K Sell
10,445
-2,420
-19% -$102K 0.06% 163
2016
Q4
$495K Hold
12,865
0.07% 158
2016
Q3
$555K Sell
12,865
-1,300
-9% -$56.1K 0.03% 235
2016
Q2
$614K Sell
14,165
-104,719
-88% -$4.54M 0.04% 226
2016
Q1
$4.82M Sell
118,884
-7,175
-6% -$291K 0.27% 114
2015
Q4
$5.09M Sell
126,059
-16,630
-12% -$671K 0.29% 108
2015
Q3
$5.49M Sell
142,689
-4,404
-3% -$169K 0.33% 102
2015
Q2
$6.13M Sell
147,093
-5,460
-4% -$227K 0.32% 100
2015
Q1
$7.04M Sell
152,553
-1,210
-0.8% -$55.8K 0.38% 96
2014
Q4
$6.57M Buy
153,763
+1,585
+1% +$67.7K 0.37% 100
2014
Q3
$7M Buy
152,178
+7,285
+5% +$335K 0.39% 96
2014
Q2
$7.75M Sell
144,893
-1,700
-1% -$90.9K 0.42% 91
2014
Q1
$7.83M Sell
146,593
-8,510
-5% -$455K 0.44% 89
2013
Q4
$8.28M Buy
155,103
+25,515
+20% +$1.36M 0.46% 86
2013
Q3
$6.5M Sell
129,588
-4,922
-4% -$247K 0.38% 106
2013
Q2
$6.72M Buy
+134,510
New +$6.72M 0.42% 100